AstraZeneca (AZN)
FDA ODAC vote on camizestrant in breast cancer
FDA ODAC vote on camizestrant in breast cancer
La Commissione Europea (CE) approva POHERDY® (pertuzumab), messo a punto da Henlius e Organon, il primo biosimilare di PERJETA (pertuzumab) approvato in Europa
Europäische Kommission erteilt Marktzulassung für POHERDY® (Pertuzumab) von Henlius und Organon, das erste in Europa zugelassene Biosimilar zu PERJETA (Pertuzumab)
Northfield Bancorp Investor Alert: Kahn Swick & Foti, LLC Investigates Merger of Northfield Bancorp, Inc. - NFBK
Thermon Group Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Thermon Group Holdings, Inc. - THR
CrowdStrike Puts Claude Opus 4.7 to Work Across the Falcon Platform and Project QuiltWorks
Webster Financial Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Webster Financial Corporation - WBS
LiveOne (Nasdaq: LVO) and Subsidiary PodcastOne (Nasdaq: PODC) Launch PodcastOneAI, Unlocking 200,000+ Hours Across $20B+ AI Training and $40B+ Data Monetization Markets
Stellar Bancorp Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Stellar Bancorp, Inc. - STEL
Change in holdings of interested parties/officers